A detailed history of Slow Capital, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Slow Capital, Inc. holds 38,083 shares of MRNA stock, worth $4.51 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares
38,083
Previous 24,365 56.3%
Holding current value
$4.51 Million
Previous $2.42 Million 67.48%
% of portfolio
0.65%
Previous 0.43%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 17, 2024

BUY
$85.37 - $115.44 $1.17 Million - $1.58 Million
13,718 Added 56.3%
38,083 $4.06 Million
Q4 2023

Jan 30, 2024

BUY
$69.51 - $104.43 $265,250 - $398,504
3,816 Added 18.57%
24,365 $2.42 Million
Q3 2023

Oct 19, 2023

BUY
$96.41 - $126.61 $543,463 - $713,700
5,637 Added 37.8%
20,549 $2.12 Million
Q2 2023

Aug 09, 2023

SELL
$118.5 - $160.53 $43,015 - $58,272
-363 Reduced 2.38%
14,912 $1.81 Million
Q1 2023

Apr 26, 2023

BUY
$135.66 - $197.02 $92,248 - $133,973
680 Added 4.66%
15,275 $2.35 Million
Q4 2022

Feb 13, 2023

BUY
$118.38 - $210.04 $16,454 - $29,195
139 Added 0.96%
14,595 $2.62 Million
Q3 2022

Oct 27, 2022

BUY
$118.07 - $194.18 $8,973 - $14,757
76 Added 0.53%
14,456 $1.71 Million
Q2 2022

Jul 28, 2022

BUY
$117.13 - $176.59 $183,074 - $276,010
1,563 Added 12.19%
14,380 $2.05 Million
Q1 2022

May 02, 2022

BUY
$126.46 - $235.05 $85,107 - $158,188
673 Added 5.54%
12,817 $2.21 Million
Q4 2021

Feb 08, 2022

BUY
$225.82 - $368.51 $122,846 - $200,469
544 Added 4.69%
12,144 $3.08 Million
Q3 2021

Oct 21, 2021

SELL
$221.9 - $484.47 $21,968 - $47,962
-99 Reduced 0.85%
11,600 $4.46 Million
Q2 2021

Jul 29, 2021

BUY
$129.91 - $234.98 $54,302 - $98,221
418 Added 3.71%
11,699 $2.75 Million
Q1 2021

May 20, 2021

BUY
$109.18 - $185.98 $22,491 - $38,311
206 Added 1.86%
11,281 $1.5 Million
Q1 2021

May 05, 2021

BUY
$109.18 - $185.98 $1.21 Million - $2.06 Million
11,075 New
11,075 $1.45 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $46.3B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Slow Capital, Inc. Portfolio

Follow Slow Capital, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Slow Capital, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Slow Capital, Inc. with notifications on news.